Learning Objectives:

1. Compare levodopa, dopamine agonists, & monoamine oxidase type B inhibitors on the management of motor symptoms & in side effect profile in those with early Parkinson disease.
2. Compare different levodopa formulations influence on the management of motor symptoms & in side effect profile in those with early Parkinson disease.
3. Compare different dopamine agonist formulations in side effect profile in those with early Parkinson disease.
4. Compare the long-term risk of disabling dyskinesia between levodopa & dopamine agonists in those with early Parkinson disease.
5. Compare the risk of impulse control disorders between levodopa, dopamine agonists, & monoamine oxidase type B inhibitors in those with early Parkinson disease.

Evaluation

Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135